The Effect of Bladder Outlet Obstruction on Bladder Cancer Recurrence and Progression.

Authors: Can, Utku (AUTHOR), Dinçer, Erdinç (AUTHOR), Coşkun, Alper (AUTHOR), Çanakçı, Cengiz (AUTHOR), Narter, Fehmi (AUTHOR)

Source: Journal of Urological Surgery. Mar2025, Vol. 12 Issue 1, p1-7. 7p.

Subject Terms: *NON-muscle invasive bladder cancer, *CANCER relapse, *CYSTOSCOPY, *LOGISTIC regression analysis, *DIVERTICULUM, *INDEPENDENT variables, *RETROSPECTIVE studies, *DESCRIPTIVE statistics, *TUMOR grading, *BLADDER diseases, *MEDICAL records, *ACQUISITION of data, *CONFIDENCE intervals, *DISEASE progression, *DISEASE risk factors, *DISEASE complications, BLADDER tumors

Small non-coding RNA profiling in patients with non-muscle invasive bladder cancer.

Authors: Cai, Jiajia¹ (AUTHOR), Yan, Zeqin¹ (AUTHOR), Zhong, Yadi^1,2 (AUTHOR), Li, Yuqing¹ (AUTHOR), Huang, Jianxu¹ (AUTHOR), Hu, Huijuan¹ (AUTHOR), Li, Yingrui^1,3 (AUTHOR), Fang, Hu^1,4 (AUTHOR) fanghu@szu.edu.cn, Wu, Song^1,3 (AUTHOR) wusong@szu.edu.cn

Source: BMC Cancer. 2/21/2025, Vol. 25 Issue 1, p1-13. 13p.

Subject Terms: *NON-muscle invasive bladder cancer, *MEDICAL sciences, *MEDICAL genetics, *NON-coding RNA, *LIFE sciences

IL-15: from discovery to FDA approval.

Authors: Li, Zihai^1,2,3 (AUTHOR), Wrangle, John^4,5 (AUTHOR), He, Kai^1,2 (AUTHOR), Sprent, Jonathan^6,7 (AUTHOR), Rubinstein, Mark P.^1,2 (AUTHOR) mark.rubinstein@osumc.edu

Source: Journal of Hematology & Oncology. 2/18/2025, Vol. 18 Issue 1, p1-5. 5p.

Subject Terms: *ANTIBODY-dependent cell cytotoxicity, *NON-muscle invasive bladder cancer, *INTERLEUKIN-2, *REGULATORY T cells, *HAIRY cell leukemia

Impact of upper tract urothelial carcinoma history on patients with non-muscle invasive bladder cancer undergoing intravesical chemotherapy.

Authors: Ji, Jiaxiang^1,2 (AUTHOR), Wang, Fei³ (AUTHOR), Lai, Chin-Hui^1,2 (AUTHOR), Wang, Mingrui^1,2 (AUTHOR), Hu, Haopu^1,2 (AUTHOR), Xu, Kexin^1,2 (AUTHOR), Xu, Tao^1,2 (AUTHOR), Hu, Hao^1,2 (AUTHOR) huhao@bjmu.edu.cn

Source: Scientific Reports. 2/18/2025, Vol. 15 Issue 1, p1-7. 7p.

Subject Terms: *NON-muscle invasive bladder cancer, *TRANSURETHRAL resection of bladder, *DISEASE risk factors, *MEDICAL sciences, *TRANSITIONAL cell carcinoma, *LOG-rank test

Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer.

Authors: Lange, Alyssa¹ (AUTHOR) alyssa.lange2@rockets.utoledo.edu, Madiraju, SriGita¹ (AUTHOR), Petros, Firas G.¹ (AUTHOR) firas.petros@utoledo.edu

Source: Cancers. Feb2025, Vol. 17 Issue 4, p636. 16p.

Subject Terms: *NON-muscle invasive bladder cancer, *CYSTECTOMY, *GENE therapy, *CANCER relapse, *INTRAVESICAL administration, *BCG vaccines, *IMMUNOTHERAPY, *CANCER chemotherapy, *IMMUNE checkpoint inhibitors, *COMBINED modality therapy, *DISEASE progression

The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer.

Authors: Bola, Becky^1,2 (AUTHOR), Hoskin, Peter J.^3,4 (AUTHOR), Sangar, Vijay^2,5 (AUTHOR), Choudhury, Ananya^3,4 (AUTHOR) ananya.choudhury@nhs.net

Source: Cancers. Feb2025, Vol. 17 Issue 4, p628. 14p.

Subject Terms: *NON-muscle invasive bladder cancer, *DRUG toxicity, *RADIOTHERAPY, *DIFFUSION of innovations, *TERMINATION of treatment, *BCG vaccines, *MEDICAL care, *INVENTORY shortages, *TUMOR markers, *RADIATION-sensitizing agents, *DNA damage, *COMBINED modality therapy, *DRUGS

Long-Term Outcomes of Intravesical Mitomycin C Administered via Electromotive Drug Administration or Conductive Chemo-Hyperthermia in Non-Muscle-Invasive Bladder Cancer.

Authors: Melgarejo-Segura, Maria Teresa^1,2 (AUTHOR) mtm.segura@gmail.com, Zambudio-Munuera, Alberto¹ (AUTHOR), Arrabal-Polo, Miguel Ángel^1,2 (AUTHOR), Lardelli-Claret, Pablo³ (AUTHOR), Pareja-Vilchez, Manuel¹ (AUTHOR), Arrabal-Martín, Miguel^1,2,3 (AUTHOR)

Source: Cancers. Feb2025, Vol. 17 Issue 3, p453. 10p.

Subject Terms: *NON-muscle invasive bladder cancer, *INTRAVESICAL administration, *CANCER relapse, *THERMOTHERAPY, *SCIENTIFIC observation, *MITOMYCINS, *TREATMENT effectiveness, *CANCER chemotherapy, *LONGITUDINAL method, *COMPARATIVE studies, *DISEASE progression

Geographic Terms: SPAIN

Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study.

Authors: Kawahara, Takashi¹ (AUTHOR) tkawahar@md.tsukuba.ac.jp, Kandori, Shuya¹ (AUTHOR) shuya79@md.tsukuba.ac.jp, Kojima, Takahiro² (AUTHOR) t.kojima@aichi-cc.jp, Mathis, Bryan J.³ (AUTHOR) bmathis@md.tsukuba.ac.jp, Shiga, Masanobu¹ (AUTHOR) mshiga@md.tsukuba.ac.jp, Nishiyama, Hiroyuki¹ (AUTHOR) nishiuro@md.tsukuba.ac.jp

Source: BMC Research Notes. 1/31/2025, Vol. 18 Issue 1, p1-6. 6p.

Subject Terms: *NON-muscle invasive bladder cancer, *ANDROGEN receptors, *ADVERSE health care events, *IMMUNOHISTOCHEMISTRY, *TUMOR markers

Symptoms and Side Effects of Bacille Calmette–Guerin Therapy for Non-Muscle Invasive Bladder Cancer as Reported by Patients: A Systematic Review.

Authors: Lahoud, John^1,2 (AUTHOR) jlah4911@uni.sydney.edu.au, Okullo, Alfin¹ (AUTHOR), Rutherford, Claudia^3,4 (AUTHOR), Smith, David P.^5,6,7,8 (AUTHOR), Costa, Daniel S. J.^2,5 (AUTHOR), Tait, Margaret-Ann³ (AUTHOR), Sengupta, Shomik^9,10,11 (AUTHOR) shomik.sengupta@monash.edu, Patel, Manish I.^1,2 (AUTHOR) manish.patel@sydney.edu.au

Source: Cancers. Jan2025, Vol. 17 Issue 2, p160. 13p.

Subject Terms: *NON-muscle invasive bladder cancer, *AMED (Information retrieval system), *MEDICAL information storage & retrieval systems, *STATISTICAL significance, *DRUG therapy, *BCG vaccines, *FISHER exact test, *TREATMENT effectiveness, *CHI-squared test, *SYSTEMATIC reviews, *MEDLINE, *DRUG efficacy, *HEALTH outcome assessment, *COUNSELING, *PSYCHOLOGY information storage & retrieval systems, *EVALUATION

Sexual-Sparing Radical Cystectomy in the Robot-Assisted Era: A Review on Functional and Oncological Outcomes.

Authors: Introini, Carlo¹ (AUTHOR), Sequi, Manfredi Bruno² (AUTHOR) manfredibruno.sequi@uniroma1.it, Ennas, Marco¹ (AUTHOR), Benelli, Andrea¹ (AUTHOR), Guano, Giovanni¹ (AUTHOR), Pastore, Antonio Luigi² (AUTHOR), Carbone, Antonio² (AUTHOR)

Source: Cancers. Jan2025, Vol. 17 Issue 1, p110. 14p.

Subject Terms: *NON-muscle invasive bladder cancer, *CYSTECTOMY, *SURGICAL robots, *FEMALE reproductive organ diseases, *PATIENT selection, *URINARY incontinence, *FUNCTIONAL assessment, *TREATMENT effectiveness, *SURGICAL complications, *MALE reproductive organ diseases, *SURGICAL margin, *SEXUAL dysfunction, *QUALITY of life, *IMPOTENCE, *DISEASE risk factors

Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer.

Authors: Arita, Yuki¹ (AUTHOR) yukiarita1113@gmail.com, Kwee, Thomas C.² (AUTHOR), Akin, Oguz¹ (AUTHOR), Shigeta, Keisuke^3,4 (AUTHOR), Paudyal, Ramesh⁵ (AUTHOR), Roest, Christian² (AUTHOR), Ueda, Ryo⁶ (AUTHOR), Lema-Dopico, Alfonso⁵ (AUTHOR), Nalavenkata, Sunny⁷ (AUTHOR), Ruby, Lisa¹ (AUTHOR), Nissan, Noam¹ (AUTHOR), Edo, Hiromi⁸ (AUTHOR), Yoshida, Soichiro⁹ (AUTHOR), Shukla-Dave, Amita^1,5 (AUTHOR), Schwartz, Lawrence H.¹ (AUTHOR)

Source: Insights into Imaging. 1/2/2025, Vol. 16 Issue 1, p1-21. 21p.

Subject Terms: *NON-muscle invasive bladder cancer, *COMPUTER-assisted image analysis (Medicine), *MEDICAL sciences, *IMAGE analysis, *IMAGE processing

Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece.

Authors: Angelopoulos, Panagiotis¹ (AUTHOR) angelopoulospanag@gmail.com, Markopoulos, Titos¹ (AUTHOR) titosmark@gmail.com, Lazarou, Lazaros¹ (AUTHOR) lazarou_laz@hotmail.com, Skolarikos, Andreas¹ (AUTHOR) andskol@yahoo.com, Stamatakos, Panagiotis² (AUTHOR) pvstamatakos@gmail.com, Papadopoulos, Georgios I.² (AUTHOR) gipapadopoulos@yahoo.com, Fragkoulis, Charalampos² (AUTHOR) harisfrag@yahoo.gr, Ntoumas, Konstantinos² (AUTHOR) ntoumask@yahoo.com, Moulavasilis, Napoleon³ (AUTHOR) napomoul@hotmail.com, Levis, Panagiotis³ (AUTHOR) panagiotislevis@yahoo.com, Papanikolaou, Dimitrios⁴ (AUTHOR) dimpapanikolaou18@gmail.com, Sokolakis, Ioannis⁴ (AUTHOR) sokolakisi@hotmail.com, Hatzimouratidis, Konstantinos⁴ (AUTHOR) promahon@otenet.gr, Tzanetakos, Charalampos⁵ (AUTHOR) c.tzanetakos@hte.gr, Psarra, Marina⁵ (AUTHOR) m.psarra@hte.gr, Mavridoglou, George⁶ (AUTHOR) ge.mavridoglou@go.uop.gr, Skriapas, Konstantinos⁷ (AUTHOR) kostas.skriapas@hotmail.com, Akrivou, Dimitra⁷ (AUTHOR) dim.s.akrivou@gmail.com, Karagiannis, Dimitrios⁷ (AUTHOR) kdimitrios@yahoo.com, Noutsos, Christos⁸ (AUTHOR) noutsos95@gmail.com

Source: Current Oncology. Jan2025, Vol. 32 Issue 1, p18. 11p.

Subject Terms: *NON-muscle invasive bladder cancer, *INTRAVESICAL administration, *CARCINOMA in situ, *PROGRESSION-free survival, *MEDICAL records

Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancer.

Authors: Rabien, Anja¹ (AUTHOR) anja.rabien@charite.de, Rong, Dezhi^1,2 (AUTHOR), Rabenhorst, Silke¹ (AUTHOR), Schlomm, Thorsten¹ (AUTHOR), Labonté, Flora¹ (AUTHOR), Hofbauer, Sebastian¹ (AUTHOR), Forey, Nathalie³ (AUTHOR), Le Calvez-Kelm, Florence³ (AUTHOR), Ecke, Thorsten H.^1,2 (AUTHOR)

Source: Scientific Reports. 12/23/2024, Vol. 14 Issue 1, p1-9. 9p.

Subject Terms: *NON-muscle invasive bladder cancer, *TELOMERASE reverse transcriptase, *BLADDER cancer, *CANCER diagnosis, *MEDICAL sciences

Comparisons of Intravesical Treatments with Mitomycin C, Gemcitabine, and Docetaxel for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: Updated Systematic Review and Meta-Analysis.

Authors: Matloubieh, Jubin E.¹ (AUTHOR) jm5889@cumc.columbia.edu, Hanelin, David² (AUTHOR) david.hanelin@einsteinmed.edu, Agalliu, Ilir^1,3 (AUTHOR) ilir.agalliu@einsteinmed.edu

Source: Cancers. Dec2024, Vol. 16 Issue 24, p4125. 19p.

Subject Terms: *THERAPEUTIC use of antineoplastic agents, *NON-muscle invasive bladder cancer, *DOCETAXEL, *RESEARCH funding, *MITOMYCINS, *META-analysis, *SYSTEMATIC reviews, *MEDLINE, *DRUG efficacy, *GEMCITABINE, *MEDICAL databases, *DISEASE relapse, *ONLINE information services, *PROGRESSION-free survival, *DISEASE progression, *EVALUATION, *DISEASE risk factors

Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer.

Authors: Patwardhan, Mugdha V.¹ (AUTHOR) mugdha.p@u.nus.edu, Kane, Toh Qin² (AUTHOR) kane9530@hotmail.com, Chiong, Edmund^1,3 (AUTHOR) surce@nus.edu.sg, Rahmat, Juwita Norasmara¹ (AUTHOR) juwita.r@nus.edu.sg, Mahendran, Ratha¹ (AUTHOR) surrm@nus.edu.sg

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 24, p13296. 15p.

Subject Terms: *NON-muscle invasive bladder cancer, *BCG immunotherapy, *GENE expression, *INTRAVESICAL administration, *MYCOBACTERIUM bovis

Bladder Cancer Highlights on UROPEDIA, Which is an E-Learning Platform of The Society of Urological Surgery in Turkiye.

Authors: Aydın, Yavuz Mert (AUTHOR), Mungan, Necmettin Aydın (AUTHOR)

Source: Journal of Urological Surgery. Dec2024, Vol. 11 Issue 4, p195-6. 6p.

Subject Terms: *NON-muscle invasive bladder cancer, *CYSTECTOMY, *BCG vaccines, *ONLINE education, *MOTION pictures, BLADDER tumors

Mycobacteria Treatment Inhibits Bladder Cancer Cell Migration, Invasion, and Anchorage-Independent Growth.

Authors: Bach-Griera, Marc¹ (AUTHOR) marcbg86@gmail.com, Hernández, Alba² (AUTHOR) alba.hernandez@uab.cat, Julián, Esther¹ (AUTHOR) esther.julian@uab.cat

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12997. 12p.

Subject Terms: *NON-muscle invasive bladder cancer, *CANCER cell migration, *BCG immunotherapy, *CELL migration, *BLADDER cancer, *MYCOBACTERIUM bovis

Peripheral Mechanisms Underlying Bacillus Calmette–Guerin-Induced Lower Urinary Tract Symptoms (LUTS).

Authors: Elmasri, Meera¹ (AUTHOR) elma0018@flinders.edu.au, Clark, Aaron¹ (AUTHOR), Grundy, Luke¹ (AUTHOR) luke.grundy@flinders.edu.au

Source: Brain Sciences (2076-3425). Dec2024, Vol. 14 Issue 12, p1203. 14p.

Subject Terms: *NON-muscle invasive bladder cancer, *BCG immunotherapy, *PATIENT compliance, *URINARY organs, *TERMINATION of treatment

PREDICTIVE VALUE OF CLAUDIN-4 EXPRESSION IN NON-MUSCLE INVASIVE UROTHELIAL BLADDER CANCER.

Alternate Title: PREDIKTIVNI ZNAČAJ EKSPRESIJE PROTEINA KLAUDIN-4 U UROTELNOM KARCINOMU MOKRAĆNE BEŠIKE BEZ ZAHVATANJA MIŠIĆNOG SLOJA.

Authors: Stojnev, Slavics^1,2 slavicastojnev@gmail.com, Ristić-Petrović, Ana^1,2, Radić, Milica^3,4, Janković Veličković, Ljubinka^1,2

Source: Acta Medica Medianae. Dec2024, Vol. 63 Issue 4, p114-121. 8p.

Subject Terms: *NON-muscle invasive bladder cancer, *STATISTICAL significance, *TRANSITIONAL cell carcinoma, *BLADDER cancer, *OVERALL survival

Nomogram for predicting all-cause mortality and cancer-specific mortality after TURBT for non-muscle-invasive bladder cancer.

Authors: Luo, Yao¹ (AUTHOR), Wei, Sujing¹ (AUTHOR), Yang, Jing¹ (AUTHOR) 1977241811@qq.com, Tan, Zaixiang^2,3,4 (AUTHOR) tanzaixiang@126.com

Source: Scientific Reports. 11/20/2024, Vol. 14 Issue 1, p1-11. 11p.

Subject Terms: *TRANSURETHRAL resection of bladder, *NON-muscle invasive bladder cancer, *RECEIVER operating characteristic curves, *RACE, *NOMOGRAPHY (Mathematics)